Multiple Myeloma Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Multiple Myeloma Medications, Costs & Savings
Pharmacist insight
Medication adherence is particularly critical for oral chemotherapy agents. I work closely with patients to manage side effects that might cause them to skip doses. Many supportive care medications — anti-nausea drugs, growth factors — are available in generic form, helping reduce the overall cost burden of cancer treatment.
Angela C. Beverly, PharmD
About Multiple Myeloma
Multiple myeloma is a type of cancer that begins in the plasma cells, a kind of white blood cell in your bone marrow. These abnormal plasma cells, called myeloma cells, multiply uncontrollably, crowding out healthy blood cells and producing abnormal proteins. This can lead to a range of serious health issues, including bone damage, kidney problems, weakened immune function, and anemia.
Symptoms often include bone pain, fatigue, frequent infections, and kidney issues, though some individuals may not experience symptoms in the early stages. Diagnosis typically involves blood and urine tests, bone marrow biopsy, and imaging scans to assess bone involvement. While there isn't a cure for multiple myeloma, advances in treatment have significantly improved patient outcomes and quality of life.
Treatments and Medications for Multiple Myeloma
Managing multiple myeloma often involves a combination of therapies tailored to the individual. Common treatments include:
- Chemotherapy: Drugs like melphalan or cyclophosphamide aim to kill cancer cells.
- Immunomodulatory Drugs (IMiDs): Medications such as lenalidomide (Revlimid), pomalidomide (Pomalyst), and thalidomide help modulate the immune system to fight myeloma cells.
- Proteasome Inhibitors: Bortezomib (Velcade), carfilzomib (Kyprolis), and ixazomib (Ninlaro) block enzymes essential for cancer cell survival.
- Monoclonal Antibodies: Daratumumab (Darzalex), elotuzumab (Empliciti), and isatuximab (Sarclisa) target specific proteins on myeloma cells.
- Steroids: Dexamethasone is often used in combination with other drugs.
- Stem Cell Transplant: An intensive treatment that replaces diseased bone marrow with healthy stem cells.
- Newer Therapies: CAR T-cell therapy and bispecific antibodies represent cutting-edge options for some patients.
Many of these medications are highly effective but come with a substantial price tag, posing a significant financial burden for patients and their families.
How TheDrugClub Helps You Save
At TheDrugClub, we understand the financial stress that comes with
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
MedlinePlus overview of Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones.
No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families. Common symptoms may include:
Bone pain, often in the back or ribs
Fractures (broken bones)
Weakness or fatigue
Weight loss
Frequent infections and fevers
Feeling very thirsty
Frequent urination
Doctors diagnose multiple myeloma using lab tests, imaging tests, and a bone marrow biopsy. Your treatment depends on how advanced the disease is and whether you have symptoms. If you have no symptoms, you may not need treatment right away. If you have symptoms, you may have chemotherapy, stem cell transplantation, radiation, or targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
Source: MedlinePlus, U.S. National Library of Medicine. MedlinePlus topic page. Topic date: 06/28/1999. MedlinePlus file date: 10/15/2026 02:30:37.
This information is educational and is not medical advice.